Vitamins aren’t FDA approved because they’re legally classified as dietary supplements, not drugs. Under a 1994 federal law called the Dietary Supplement Health and Education Act (DSHEA), supplements don’t need to prove they’re safe or effective before going on sale. The FDA only steps in after a product is already on shelves, and only if there’s evidence it’s causing harm.
This surprises a lot of people. The same agency that requires years of clinical trials before a new medication can reach your pharmacy has essentially no authority to review a vitamin before you buy it. That’s not an oversight. It’s the system Congress designed.
How the 1994 Law Changed Everything
Before DSHEA, the FDA had been moving toward regulating certain supplements more like drugs. The supplement industry and consumer advocacy groups pushed back, arguing that the government shouldn’t create “unreasonable regulatory barriers limiting or slowing the flow of safe products and accurate information to consumers.” Congress agreed, and DSHEA passed with broad bipartisan support.
The law created a distinct legal category: the “dietary supplement.” This category includes vitamins, minerals, herbs, amino acids, probiotics, and various botanical extracts. By defining these products as a subcategory of food rather than drugs, Congress effectively removed the requirement for pre-market approval. A pharmaceutical company must prove its drug is safe and effective through controlled trials before selling it. A supplement company has no such obligation.
DSHEA also flipped the burden of proof. If the FDA believes a supplement is dangerous, it’s the government’s job to prove it, not the manufacturer’s job to prove the product is safe. The law states this explicitly: “the United States shall bear the burden of proof on each element to show that a dietary supplement is adulterated.” This makes pulling a harmful supplement off the market a slow, resource-intensive process.
What the FDA Can and Can’t Do
The FDA does still regulate supplements in several ways. It just does so after they’re already being sold, not before. Manufacturers must follow current Good Manufacturing Practice (cGMP) rules, which cover sanitation, equipment maintenance, quality control testing, batch records, and employee qualifications. These rules are meant to ensure that what’s on the label is actually in the bottle and that products aren’t contaminated during production.
Manufacturers are also required to report serious adverse events to the FDA and to include a domestic address or phone number on the label so consumers can report problems. If a supplement contains a “new dietary ingredient,” one not sold before October 1994, the company must notify the FDA and provide information showing the ingredient is reasonably expected to be safe. But that notification isn’t the same as approval. The FDA doesn’t sign off on it the way it would a new drug application.
The FDA can issue warning letters, seize products, and pursue criminal charges against companies that sell adulterated or misbranded supplements. It can also act against any supplement marketed with claims to “treat, prevent, or cure” a specific disease, because making that kind of claim turns the product into an unapproved drug in the eyes of the law.
Why Your Vitamin Bottle Has That Disclaimer
If you’ve ever read the fine print on a supplement label, you’ve probably seen something like: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.” That disclaimer is legally required.
Supplements are allowed to make what are called structure/function claims. These describe how a nutrient affects normal body processes. “Calcium builds strong bones” is a permitted claim. “Fiber maintains bowel regularity” is another. What a supplement cannot say is that it treats osteoporosis or prevents colon cancer. Those are drug claims, and making them without FDA approval is illegal.
The line between these two types of claims can feel blurry to consumers. A vitamin labeled “supports immune health” sounds a lot like it’s saying it prevents illness, but it stays just within the legal boundary. This is one of the most common criticisms of the current system: the language on supplement labels can imply benefits that haven’t been proven through rigorous testing.
No Approval Doesn’t Mean No Standards
The lack of FDA approval doesn’t mean all supplements are unregulated or unreliable, but it does mean quality varies widely between brands. Without pre-market review, some products on the shelf contain less of an ingredient than the label claims, or more, or include contaminants that shouldn’t be there at all.
Third-party certification programs exist to fill this gap. NSF International, for example, tests supplements against NSF/ANSI 173, the only American National Standard for dietary supplement ingredients. Their process includes verifying that the contents match the label, screening for harmful contaminants, and conducting annual audits with periodic retesting. The United States Pharmacopeia (USP) runs a similar verification program. For athletes, NSF’s Certified for Sport program screens products for over 280 substances banned by major athletic organizations, including stimulants, steroids, and narcotics.
If you’re choosing a vitamin supplement and want greater confidence in what you’re getting, look for one of these third-party seals on the packaging. They don’t test whether the supplement actually delivers the health benefit you’re hoping for, but they do confirm the product contains what it says and isn’t contaminated.
Potential Changes Ahead
The supplement market has grown enormously since 1994, and the regulatory framework hasn’t kept pace. One significant gap: manufacturers aren’t currently required to register their individual products with the FDA, which means the agency doesn’t have a complete picture of what’s being sold. The Dietary Supplement Listing Act, introduced in Congress in 2026, would change that by requiring manufacturers to file product listings with the FDA. If a company failed to comply, its supplement would be considered misbranded under federal law.
This kind of mandatory product listing wouldn’t amount to pre-market approval, but it would give the FDA a clearer view of the marketplace and make enforcement easier. For now, the fundamental structure of DSHEA remains intact: vitamins and other supplements reach consumers without the same safety and efficacy review that prescription and over-the-counter drugs must pass.